Biogen swung to a loss as results were hurt by a double-digit decline in revenue from its core multiple sclerosis treatments.

Advancements in MS include promising therapies like BTK inhibitors and myelin repair, evolving biomarkers, and a focus on cognition, signaling a promising future in precision medicine.

Scientists at the 2026 ACTRIMS forum meet to assess current approaches and explore new directions for MS research and care.

A new study reveals how Epstein-Barr virus may provoke immune cells to attack the brain, offering fresh hope for treating ...

TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the presentation of data highlighting BRIUMVI® (ublituximab-xiiy), to be presented at the Americas Committee for Treatment and Research in ...

Could plastic byproducts and forever chemicals found in drinking water cause your body to attack your own nervous system? New ...

For decades, multiple sclerosis (MS) has been defined primarily by its symptoms, rather than its underlying biology. Now, a ...

Specialists in multiple sclerosis will gather in San Diego for ACTRIMS Forum 2026, Feb. 5-7, where the theme will be “MS at a ...

Researchers at UC San Francisco have uncovered a new clue to how Epstein-Barr virus (EBV) could contribute to multiple ...

Researchers developed a mouse model of multiple sclerosis that captures the features of progression independent of relapse ...

Music activates multiple parts of the brain. For people with MS, a choir is exploring what singing together can offer.

Could plastic byproducts and forever chemicals found in drinking water cause your body to attack your own nervous system?